How Much Does Testosterone Cypionate Cost in District of Columbia in 2026?

DC Cash-Pay Prices for Generic Testosterone Cypionate

The average cash-pay price for a one-month supply of generic testosterone cypionate (200 mg/mL, 1 mL vial) at District of Columbia retail pharmacies sits around $60 in 2026. That figure reflects pricing across major chains and independent pharmacies within the District. The manufacturer list price, by contrast, hovers near $100 per month.

Cash-pay pricing varies by pharmacy, sometimes substantially. A CVS in Northwest DC may charge differently than an independent pharmacy in Southeast. Calling ahead or using a pharmacy price comparison tool before filling your script can save $10 to $30 per fill. Multi-dose vials (10 mL) typically reduce the per-dose cost by 30 to 50 percent compared to single-dose vials, though not every pharmacy stocks them.

Testosterone cypionate is a Schedule III controlled substance under federal law, which means it requires a valid prescription and cannot be purchased over the counter. DC follows federal scheduling without additional state-level restrictions on testosterone prescribing for diagnosed hypogonadism.

The Testosterone Trials (T-Trials), a coordinated set of seven placebo-controlled studies published in the New England Journal of Medicine, enrolled 790 men aged 65 and older with serum testosterone below 275 ng/dL. Participants receiving testosterone gel for one year showed improvements in sexual function, walking distance, and mood compared to placebo. These findings helped establish the clinical rationale for testosterone replacement in symptomatic hypogonadal men, the same population now seeking affordable access in DC.

DC Medicaid Coverage for Testosterone Cypionate

District of Columbia Medicaid covers testosterone cypionate for male hypogonadism, but the program requires prior authorization (PA) before it will pay. PA approval typically involves documentation of two morning serum testosterone levels below the lab reference range (generally below 264 to 300 ng/dL, depending on the assay), plus clinical signs or symptoms of androgen deficiency.

The PA process in DC Medicaid generally takes 24 to 72 hours when submitted electronically. Your prescriber's office submits the request alongside lab results and a brief clinical rationale. Denials can be appealed, and DC Medicaid must respond to expedited appeals within 72 hours per federal Medicaid requirements.

Copays under DC Medicaid for covered prescriptions are minimal. Most enrollees pay $0 to $3 per fill for generic testosterone cypionate once the PA is approved. The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with "unequivocally low serum testosterone concentrations" combined with consistent symptoms, and DC Medicaid's PA criteria align closely with this standard.

Dr. Shalender Bhasin, one of the lead investigators of the T-Trials and a professor at Harvard Medical School, has stated: "Testosterone treatment should be offered to men with symptomatic testosterone deficiency after a thorough discussion of the potential benefits and risks." DC Medicaid's PA pathway effectively operationalizes this guidance by requiring documented deficiency before approving coverage.

Commercial Insurance Coverage in DC

Most major commercial health plans available through DC Health Link (the District's ACA marketplace) and employer-sponsored plans cover generic testosterone cypionate on their formularies. Typical coverage patterns include placement on Tier 1 or Tier 2 of the pharmacy benefit, with copays ranging from $5 to $30 per month depending on the specific plan.

Plans from CareFirst BlueCross BlueShield, Kaiser Permanente Mid-Atlantic, Aetna, and UnitedHealthcare all generally include testosterone cypionate with PA requirements similar to Medicaid's. The American Urological Association's guideline on testosterone deficiency recommends confirmatory testing with two separate morning total testosterone measurements, and most DC insurers require this documentation before authorizing coverage.

Step therapy is uncommon for injectable testosterone cypionate. Unlike topical testosterone gels (which carry higher price tags, often $300 to $500 per month for brand-name formulations), the injectable form is already a low-cost generic. Insurers rarely impose step therapy on a drug that costs less than the alternatives they would require patients to try first.

If your plan denies coverage, requesting a formulary exception with supporting clinical documentation succeeds in a significant percentage of cases. Your prescriber can cite the Endocrine Society guideline and the patient's lab values as the basis for medical necessity.

Compounded Testosterone Cypionate in DC

Compounded testosterone cypionate is legal in the District of Columbia through licensed 503A pharmacies. These pharmacies operate under a patient-specific prescription from a licensed prescriber and are regulated by the DC Board of Pharmacy.

The average price for compounded testosterone cypionate in DC runs about $80 per month. That is higher than the generic manufactured product ($60), which may seem counterintuitive. The price difference reflects several factors: 503A pharmacies compound in smaller batches, use pharmacy-grade raw ingredients, and absorb compliance costs that differ from large-scale manufacturing.

Why would someone choose compounded over manufactured? A few clinical scenarios make compounding the better option:

• Dose customization. A patient needing 120 mg per week (rather than the standard 100 mg or 200 mg vial concentrations) can get a concentration prepared to their exact dose.
• Preservative sensitivity. Some patients react to benzyl alcohol or other preservatives in manufactured vials. Compounding pharmacies can formulate without those additives.
• Combination products. Some prescribers order testosterone cypionate combined with anastrozole in a single injection, which is only available through compounding.

The FDA's guidance on 503A compounding requires that compounded drugs be prepared based on a valid individual prescription and that the pharmacy not compound regularly or in inordinate amounts of any drug that is essentially a copy of a commercially available product. DC pharmacies must comply with both federal and District regulations.

Not all compounded testosterone products are equal. Verify that your compounding pharmacy holds current DC licensure, follows USP 797 sterile compounding standards, and provides certificates of analysis for potency testing. These safeguards help ensure the product you receive contains the labeled concentration of testosterone cypionate.

Telehealth TRT Prescribing in District of Columbia

DC permits telehealth prescribing of testosterone cypionate. Prescribers licensed in the District can evaluate patients via video consultation, order labs, and issue prescriptions for controlled substances including Schedule III testosterone.

The Ryan Haight Act requires at least one valid medical evaluation before prescribing controlled substances online. Following the pandemic-era flexibilities, the DEA finalized rules that permit telehealth prescribing of Schedule III through V controlled substances after an audio-video evaluation, without requiring an in-person visit, provided the prescriber complies with state-specific requirements. DC does not impose additional restrictions beyond the federal framework for testosterone prescribing via telehealth.

Telehealth TRT clinics operating in DC typically charge between $99 and $199 per month for their services, which usually bundle the consultation, lab orders, and sometimes the medication itself. These costs are separate from the pharmacy price of the drug. Some patients find that the convenience offsets the additional expense, while others prefer using their insurance through a traditional in-person provider to minimize out-of-pocket costs. The arithmetic matters. A patient with insurance paying a $10 copay at a retail pharmacy plus a $30 in-network office visit copay spends less annually than one paying $149 per month for an all-inclusive telehealth clinic.

The American Association of Clinical Endocrinology (AACE) has endorsed telehealth as an appropriate modality for managing stable endocrine conditions, including testosterone replacement, provided that appropriate monitoring (periodic serum testosterone, hematocrit, and PSA levels) continues at recommended intervals.

How to Find the Lowest Price in DC

Getting the cheapest testosterone cypionate in the District requires a systematic approach rather than guessing.

Step 1: Check your insurance formulary. Log into your plan's member portal or call the pharmacy benefit number on your insurance card. Confirm testosterone cypionate is covered and determine your copay tier. If covered, your retail pharmacy copay is almost certainly the cheapest route.

Step 2: Use discount tools for cash-pay. If you are uninsured or your plan does not cover testosterone, pharmacy discount cards (GoodRx, RxSaver, SingleCare) aggregate pricing from DC pharmacies and can reduce the cash price below the standard retail rate. Prices through these platforms fluctuate, so check before each fill.

Step 3: Ask about multi-dose vials. A 10 mL vial of testosterone cypionate 200 mg/mL contains roughly 8 to 10 weeks of medication for a typical 100 to 200 mg per week dose. Per-dose cost drops meaningfully compared to buying individual 1 mL vials each week. Not all pharmacies or insurance plans dispense multi-dose vials, so ask specifically.

Step 4: Compare compounding pharmacies. If you need a compounded formulation, get quotes from at least two DC-licensed 503A pharmacies. The National Association of Boards of Pharmacy maintains a database of verified pharmacies. Prices for identical compounded formulations can vary by 20 to 40 percent between pharmacies.

Step 5: Consider manufacturer savings cards. Some generic manufacturers offer savings programs that reduce copays for commercially insured patients. These do not apply to Medicaid or other government-funded programs per federal anti-kickback statute restrictions, but they can cut $10 to $25 off a commercial copay.

A study published in JAMA Internal Medicine found that out-of-pocket costs are a significant barrier to medication adherence for testosterone therapy, with patients paying more than $30 per month being more likely to discontinue treatment within six months. Finding the lowest available price is not just about savings; consistent access supports the therapeutic outcomes demonstrated in the T-Trials.

Monitoring Costs Beyond the Medication

The sticker price of testosterone cypionate is only part of the total cost of TRT. Monitoring labs add expense that patients sometimes overlook when budgeting for therapy.

The Endocrine Society guideline recommends checking serum total testosterone at 3 to 6 months after starting therapy, then annually. Hematocrit monitoring is required because testosterone stimulates erythropoiesis, and polycythemia (hematocrit above 54 percent) is the most common adverse effect of injectable testosterone. PSA should be measured at baseline and at 3 to 6 months, then per standard prostate cancer screening guidelines.

In DC, a basic hormone panel (total testosterone, free testosterone, hematocrit/CBC, PSA) costs $50 to $150 at cash-pay labs like Quest Diagnostics or Labcorp without insurance. With insurance, lab copays are typically $0 to $20 per draw. Some telehealth TRT clinics include lab work in their monthly fee, though the specific panels may be less comprehensive than what an endocrinologist would order.

Dr. Abraham Morgentaler, associate clinical professor of urology at Harvard Medical School, has noted: "Monitoring is not optional in testosterone therapy. The safety of long-term treatment depends on regular surveillance of hematocrit, PSA, and metabolic parameters." This ongoing monitoring adds between $100 and $400 per year to the total cost of TRT, depending on insurance status and the number of lab draws ordered.

DC-Specific Discount and Assistance Programs

The District of Columbia operates several programs that can reduce prescription costs for residents who qualify.

DC Healthcare Alliance covers uninsured DC residents who do not qualify for Medicaid. The program provides prescription drug coverage, and testosterone cypionate is included when medically necessary. Enrollment requires DC residency and income documentation through the DC Department of Human Services.

340B Drug Pricing Program. Several DC safety-net clinics and federally qualified health centers (FQHCs) participate in the 340B program, which allows them to purchase outpatient drugs at significantly reduced prices. Patients seen at these clinics may access testosterone cypionate at a fraction of the retail price. Unity Health Care, the largest FQHC system in DC, operates multiple locations throughout the District.

Patient assistance programs (PAPs) from generic manufacturers are less common than for brand-name drugs, but some exist. Check NeedyMeds for current testosterone cypionate assistance programs, though availability changes quarterly.

The Health Resources and Services Administration (HRSA) reports that 340B pricing can reduce drug costs by 25 to 50 percent compared to retail. For a DC resident without insurance, filling testosterone cypionate through a 340B-eligible clinic could bring the monthly cost below $30.

Injectable Testosterone Cypionate vs. Other Formulations: DC Pricing

Testosterone cypionate injection is the most affordable testosterone replacement option in DC by a wide margin. Here is how it compares to alternative formulations available in the District:

• Testosterone cypionate injection (generic): ~$60/month cash, $5 to $30/month with insurance
• Testosterone enanthate injection (generic): ~$55 to $70/month cash, comparable insurance copays
• Testosterone gel 1.62% (generic AndroGel): ~$150 to $250/month cash, $30 to $75/month with insurance
• Testosterone nasal gel (Natesto): ~$500 to $700/month cash, often Tier 3 or non-formulary
• Testosterone pellets (Testopel): ~$500 to $800 per insertion every 3 to 6 months, variable insurance coverage

The FDA's Approved Drug Products database lists multiple ANDA-approved generic manufacturers of testosterone cypionate injection, and this competitive generic market keeps prices low. The availability of multiple generic options also gives pharmacies and insurers negotiating power that benefits the end consumer.

For most DC patients, generic injectable testosterone cypionate provides the best combination of efficacy, cost, and dosing flexibility. The twice-weekly subcutaneous injection protocol, which uses smaller needles (27 to 30 gauge) and produces more stable serum levels than weekly intramuscular injections, has gained adoption among TRT prescribers in the District based on pharmacokinetic data showing reduced peak-to-trough variation with more frequent, smaller doses (Endocrine Reviews, 2018).